IMV Inc. (IMVIF) Financials

IMVIF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2022 31.3 million 38.0 million
Sept. 30, 2022 32.0 million 38.3 million
June 30, 2022 40.6 million 38.1 million
March 31, 2022 40.8 million 29.1 million

IMVIF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2022 -6.5 million 684000
Sept. 30, 2022 -9.8 million ?
June 30, 2022 -7.5 million ?
March 31, 2022 -10.1 million ?

IMVIF Net Income

No data available :(

IMVIF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2022 21.2 million 27.4 million 1.4 million
Sept. 30, 2022 21.6 million 27.2 million 1.4 million
June 30, 2022 31.2 million 28.1 million 1.5 million
March 31, 2022 28.6 million 18.2 million 1.6 million

IMVIF Shares Outstanding

No data available :(

IMVIF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2022 207000 4.6 million 4.0 million -316009
Sept. 30, 2022 219329 5.6 million 3.6 million -
June 30, 2022 596569 6.0 million 4.4 million -
March 31, 2022 32393 6.7 million 3.9 million -

IMVIF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2022 - 322486
Sept. 30, 2022 - 271819
June 30, 2022 - 216142
March 31, 2022 - 176137

IMVIF

Price: $0

52 week price:
0.00
0.01

Earnings Per Share: -0.46 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 23423

Links: